• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过乙肝病毒载体进行的干扰素基因转移可有效抑制野生型病毒感染。

Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection.

作者信息

Protzer U, Nassal M, Chiang P W, Kirschfink M, Schaller H

机构信息

Zentrum für Molekulare Biologie Heidelberg, University of Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany.

出版信息

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10818-23. doi: 10.1073/pnas.96.19.10818.

DOI:10.1073/pnas.96.19.10818
PMID:10485909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC17966/
Abstract

Hepatitis B viruses specifically target the liver, where they efficiently infect quiescent hepatocytes. Here we show that human and avian hepatitis B viruses can be converted into vectors for liver-directed gene transfer. These vectors allow hepatocyte-specific expression of a green fluorescent protein in vitro and in vivo. Moreover, when used to transduce a type I interferon gene, expression of interferon efficiently suppresses wild-type virus replication in the duck model of hepatitis B virus infection. These data suggest local cytokine production after hepatitis-B-virus-mediated gene transfer as a promising concept for the treatment of acquired liver diseases, including chronic hepatitis B.

摘要

乙型肝炎病毒特异性靶向肝脏,在那里它们能有效感染静止的肝细胞。我们在此表明,人类和禽类乙型肝炎病毒可被转化为用于肝脏定向基因转移的载体。这些载体在体外和体内均可实现绿色荧光蛋白的肝细胞特异性表达。此外,当用于转导I型干扰素基因时,干扰素的表达能在乙型肝炎病毒感染的鸭模型中有效抑制野生型病毒复制。这些数据表明,乙型肝炎病毒介导的基因转移后产生局部细胞因子是治疗包括慢性乙型肝炎在内的获得性肝脏疾病的一个有前景的概念。

相似文献

1
Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection.通过乙肝病毒载体进行的干扰素基因转移可有效抑制野生型病毒感染。
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10818-23. doi: 10.1073/pnas.96.19.10818.
2
Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.腺病毒载体介导的乙型肝炎病毒基因组向培养细胞和小鼠的转移:跨越种属屏障
J Virol. 2001 Jun;75(11):5108-18. doi: 10.1128/JVI.75.11.5108-5118.2001.
3
Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.新型重组乙型肝炎病毒载体可有效将蛋白和 RNA 编码基因递送至原代肝细胞。
J Virol. 2013 Jun;87(12):6615-24. doi: 10.1128/JVI.03328-12. Epub 2013 Apr 3.
4
Hepatitis B virus vector carries a foreign gene into liver cells in vitro.乙肝病毒载体在体外将外源基因导入肝细胞。
Virus Genes. 2002 Jun;24(3):215-24. doi: 10.1023/a:1015320314201.
5
Minicircle DNA vector expressing interferon-lambda-3 inhibits hepatitis B virus replication and expression in hepatocyte-derived cell line.微环 DNA 载体表达干扰素-λ-3 抑制人源性肝细胞系中乙型肝炎病毒的复制和表达。
BMC Mol Cell Biol. 2020 Feb 18;21(1):6. doi: 10.1186/s12860-020-00250-9.
6
Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus.重组鸭干扰素:一种用于研究干扰素抗乙型肝炎病毒作用模式的新型试剂。
Virology. 1995 Oct 1;212(2):641-9. doi: 10.1006/viro.1995.1522.
7
Presence of replicating virus in recombinant hepadnavirus stocks results from recombination and can be eliminated by the use of a packaging cell line.重组嗜肝DNA病毒储备液中复制型病毒的存在是由重组导致的,可通过使用包装细胞系将其消除。
J Virol. 2003 Mar;77(5):2873-81. doi: 10.1128/jvi.77.5.2873-2881.2003.
8
Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.肝细胞通过依赖极性的机制基底外侧转运和分泌乙型肝炎病毒。
J Virol. 2011 Dec;85(23):12474-81. doi: 10.1128/JVI.05344-11. Epub 2011 Sep 21.
9
Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.腺病毒基因转移后γ干扰素在肝脏中的特异性表达可控制小鼠体内的乙型肝炎病毒复制。
Gene Ther. 2005 Apr;12(8):668-77. doi: 10.1038/sj.gt.3302449.
10
Approach to establishing a liver targeting gene therapeutic vector using naturally occurring defective hepatitis B viruses devoid of immunogenic T cell epitope.利用缺乏免疫原性T细胞表位的天然存在的缺陷型乙型肝炎病毒构建肝脏靶向基因治疗载体的方法。
Virus Res. 2002 May 10;85(2):187-97. doi: 10.1016/s0168-1702(02)00043-6.

引用本文的文献

1
The Evolution of Cell Culture Systems to Study Hepatitis B Virus Pathogenesis and Antiviral Susceptibility.用于研究乙型肝炎病毒发病机制和抗病毒敏感性的细胞培养系统的演变
Viruses. 2025 Jul 29;17(8):1057. doi: 10.3390/v17081057.
2
Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.在恒河猴中进行人NTCP的肝脏特异性转基因表达可使原代肝细胞对乙肝病毒易感。
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2413771122. doi: 10.1073/pnas.2413771122. Epub 2025 Feb 12.
3
Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes.乙型肝炎病毒通过靶向脂质转运途径感染肝细胞。
Cell Mol Gastroenterol Hepatol. 2023;16(2):201-221. doi: 10.1016/j.jcmgh.2023.03.011. Epub 2023 Apr 11.
4
DNA Engineering and Hepatitis B Virus Replication.DNA工程与乙型肝炎病毒复制
Front Microbiol. 2021 Nov 11;12:783040. doi: 10.3389/fmicb.2021.783040. eCollection 2021.
5
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.干扰素介导的预防呼吸道病毒的保护作用由一种缺乏非结构蛋白 1 的原型减毒活流感病毒疫苗提供。
Sci Rep. 2021 Nov 12;11(1):22164. doi: 10.1038/s41598-021-01780-8.
6
Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus Vaccine.一种原型减毒活流感病毒疫苗对呼吸道病毒的预防性保护作用。
Res Sq. 2021 Aug 13:rs.3.rs-668116. doi: 10.21203/rs.3.rs-668116/v1.
7
Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.转染后 Cre/LoxP-HBV 质粒产生重组共价闭合环状 DNA 基因组。
Virus Res. 2021 Jan 15;292:198224. doi: 10.1016/j.virusres.2020.198224. Epub 2020 Nov 6.
8
Minicircle DNA vector expressing interferon-lambda-3 inhibits hepatitis B virus replication and expression in hepatocyte-derived cell line.微环 DNA 载体表达干扰素-λ-3 抑制人源性肝细胞系中乙型肝炎病毒的复制和表达。
BMC Mol Cell Biol. 2020 Feb 18;21(1):6. doi: 10.1186/s12860-020-00250-9.
9
Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines.构建携带分泌型荧光素酶报告基因的复制型乙型肝炎病毒载体,并建立新的乙型肝炎病毒复制和表达细胞系。
World J Gastroenterol. 2019 Oct 21;25(39):5961-5972. doi: 10.3748/wjg.v25.i39.5961.
10
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis.SAMHD1 在调控 HBV cccDNA 和 RT 依赖性颗粒发生中的双重作用。
Life Sci Alliance. 2019 Mar 27;2(2). doi: 10.26508/lsa.201900355. Print 2019 Apr.

本文引用的文献

1
Treatment of chronic viral hepatitis.慢性病毒性肝炎的治疗
Antivir Chem Chemother. 1998 Nov;9(6):449-60. doi: 10.1177/095632029800900601.
2
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.拉米夫定治疗慢性乙型肝炎的一年期试验。亚洲肝炎拉米夫定研究组。
N Engl J Med. 1998 Jul 9;339(2):61-8. doi: 10.1056/NEJM199807093390201.
3
Human gene therapy.人类基因治疗。
Nature. 1998 Apr 30;392(6679 Suppl):25-30. doi: 10.1038/32058.
4
Glucagon treatment interferes with an early step of duck hepatitis B virus infection.胰高血糖素治疗会干扰鸭乙型肝炎病毒感染的早期步骤。
J Virol. 1998 Apr;72(4):2600-6. doi: 10.1128/JVI.72.4.2600-2606.1998.
5
Development of replicative and nonreplicative hepatitis B virus vectors.
Gene Ther. 1997 Dec;4(12):1330-40. doi: 10.1038/sj.gt.3300544.
6
Why are hepadnaviruses DNA and not RNA viruses?为什么嗜肝病毒是DNA病毒而不是RNA病毒?
Trends Microbiol. 1997 Nov;5(11):447-50. doi: 10.1016/s0966-842x(97)01141-4.
7
Gene therapy.基因治疗
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12744-6. doi: 10.1073/pnas.94.24.12744.
8
Novel molecular approaches toward therapy of chronic hepatitis B.
Arch Virol. 1997;142(3):611-28. doi: 10.1007/s007050050107.
9
Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.慢性病毒性肝炎的基因治疗:核酶、反义寡核苷酸和显性负性突变体。
Hepatology. 1997 Aug;26(2):251-5. doi: 10.1002/hep.510260237.
10
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.白细胞介素-12诱导Th1细胞因子对慢性乙型肝炎病毒清除很重要。
J Clin Invest. 1997 Jun 15;99(12):3025-33. doi: 10.1172/JCI119498.